ClinicalTrials.Veeva

Menu

Stress, Diurnal Cortisol, and Breast Cancer Survival

Stanford University logo

Stanford University

Status

Completed

Conditions

Breast Cancer

Treatments

Drug: Sandostatin

Study type

Observational

Funder types

Other
NIH

Identifiers

NCT00226967
IRB-12273
76389 (Other Identifier)
BRSADJ0006 (Other Identifier)

Details and patient eligibility

About

The purpose of this study is to learn about the effects of stress on hormones, the relationship between these hormones and cancer progression.

Full description

The purpose of this study is to investigate stress and tonic activation of diurnal cortisol in aging metastatic breast cancer patients; feedback inhibition & activation of cortisol; and stress-induced phasic activation of cortisol.

Enrollment

115 estimated patients

Sex

Female

Ages

35+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Diagnosis of recurrent or metastatic breast cancer.
  2. Karnofsky of 70% or greater.
  3. Proficient enough in English to be able to take questionnaires and participate in the required tasks.
  4. Living within the Greater Bay Area.
  5. Age 35 or older .

Exclusion criteria

  1. Positive supraclavicular lymph nodes as the only metastatic lesion at the time of initial diagnosis.
  2. Active cancers within the past 10 years other than breast cancer, basal cell or squamous cell carcinomas of the skin, or in situ cancer of the cervix.
  3. Any other serious medical condition that will effect short term survival
  4. History of major psychiatric illness for which patient was hospitalized or medicated, with the exception of depression or anxiety
  5. A diagnosis of diabetes.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems